 SEATTLE and VANCOUVER, British Columbia, July 28, 2022 GLOBE NEWSWIRE -- Achieve Life Sciences, Inc. NASDAQ: ACHV, a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced it will report its second quarter financial results and provide an update on the cytisinicline development program on Thursday, August 11, 2022, at 4:30 PM EDT. 